SYROS PHARMACEUTICALS, INC. Revenue
SYROS PHARMACEUTICALS, INC. reported Revenue of $9.94 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-12-31 was $386.00K.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-09-30 was $3.76M, a 3.32% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-06-30 was $2.83M, a 54.86% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-03-31 was $2.95M, a 45.97% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $9.94M, a 33.23% decline from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $14.88M, a 36.65% decline from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $23.49M, a 55.62% increase from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $15.09M, a 661.50% increase from fiscal 2019.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $4.15M derived: sum of 2 quarters · filed 2024-10-31 | $6.98M derived: sum of 3 quarters · filed 2024-10-31 | $9.94M 10-K · filed 2024-03-27 | ||
| 2023-09-30 | $3.76M 10-Q · filed 2024-10-31 | $6.59M derived: sum of 2 quarters · filed 2024-10-31 | $9.55M 10-Q · filed 2024-10-31 | $8.79M derived: sum of 4 quarters · filed 2024-10-31 | ||
| 2023-06-30 | $2.83M 10-Q · filed 2024-07-31 | $5.79M 10-Q · filed 2024-07-31 | $5.03M derived: sum of 3 quarters · filed 2024-07-31 | $8.92M derived: sum of 4 quarters · filed 2024-07-31 | ||
| 2023-03-31 | $2.95M 10-Q · filed 2024-05-14 | $2.20M derived: sum of 2 quarters · filed 2024-05-14 | $6.09M derived: sum of 3 quarters · filed 2024-05-14 | $12.37M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $3.14M derived: sum of 2 quarters · filed 2024-03-27 | $9.41M derived: sum of 3 quarters · filed 2024-03-27 | $14.88M 10-K · filed 2024-03-27 | ||
| 2022-09-30 | $3.89M 10-Q · filed 2023-11-14 | $10.17M derived: sum of 2 quarters · filed 2023-11-14 | $15.63M 10-Q · filed 2023-11-14 | $23.44M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $6.28M 10-Q · filed 2023-08-08 | $11.74M 10-Q · filed 2023-08-08 | $19.55M derived: sum of 3 quarters · filed 2023-08-08 | $25.24M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $5.47M 10-Q · filed 2023-05-10 | $13.27M derived: sum of 2 quarters · filed 2023-05-10 | $18.97M derived: sum of 3 quarters · filed 2023-05-10 | $24.13M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $13.50M derived: sum of 2 quarters · filed 2023-03-02 | $18.66M derived: sum of 3 quarters · filed 2023-03-02 | $23.49M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $5.70M 10-Q · filed 2022-11-14 | $10.86M derived: sum of 2 quarters · filed 2022-11-14 | $15.69M 10-Q · filed 2022-11-14 | $21.38M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $5.16M 10-Q · filed 2022-08-09 | $9.99M 10-Q · filed 2022-08-09 | $15.69M derived: sum of 3 quarters · filed 2022-08-09 | $19.52M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $4.83M 10-Q · filed 2022-05-16 | $10.53M derived: sum of 2 quarters · filed 2022-05-16 | $14.35M derived: sum of 3 quarters · filed 2022-05-16 | $17.54M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $5.70M 10-K · filed 2021-03-04 | $9.53M derived: sum of 2 quarters · filed 2021-11-05 | $12.71M derived: sum of 3 quarters · filed 2021-11-05 | $15.09M 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $3.83M 10-Q · filed 2021-11-05 | $7.02M derived: sum of 2 quarters · filed 2021-11-05 | $9.39M 10-Q · filed 2021-11-05 | $9.90M derived: sum of 4 quarters · filed 2021-11-05 | ||
| 2020-06-30 | $3.19M 10-Q · filed 2021-08-05 | $5.57M 10-Q · filed 2021-08-05 | $6.08M derived: sum of 3 quarters · filed 2021-08-05 | $6.63M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $2.38M 10-Q · filed 2021-05-06 | $2.89M derived: sum of 2 quarters · filed 2021-05-06 | $3.44M derived: sum of 3 quarters · filed 2021-05-06 | $3.91M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $508.00K 10-K · filed 2021-03-04 | $1.07M derived: sum of 2 quarters · filed 2021-03-04 | $1.53M derived: sum of 3 quarters · filed 2021-03-04 | $1.98M 10-K · filed 2022-03-15 | $2.00M 10-K · filed 2020-03-05 | |
| 2019-09-30 | $558.00K 10-K · filed 2021-03-04 | $600.00K 10-Q · filed 2019-11-12 | $1.02M derived: sum of 2 quarters · filed 2021-03-04 | $1.50M 10-Q · filed 2019-11-12 | $2.32M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $462.00K 10-K · filed 2021-03-04 | $500.00K 10-Q · filed 2019-08-01 | $900.00K 10-Q · filed 2019-08-01 | $1.77M derived: sum of 3 quarters · filed 2021-03-04 | $2.17M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | $454.00K 10-K · filed 2021-03-04 | $500.00K 10-Q · filed 2019-05-01 | $1.30M derived: sum of 2 quarters · filed 2021-03-04 | $1.70M derived: sum of 3 quarters · filed 2021-03-04 | $2.10M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | $850.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.25M derived: sum of 2 quarters · filed 2021-03-04 | $1.65M derived: sum of 3 quarters · filed 2021-03-04 | $2.05M 10-K · filed 2021-03-04 | $2.10M 10-K · filed 2019-03-07 | |
| 2018-09-30 | $400.00K 10-Q · filed 2019-11-12 | $800.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.20M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-01 | $700.00K 10-Q · filed 2019-08-01 | ||||
| 2018-03-31 | $400.00K 10-Q · filed 2019-05-01 |